Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Quetiapine

Is Quetiapine legal in Sri Lanka?

Confirmed against a primary sourceVerified September 17, 2026
Legal status
Not a dangerous drug under Sri Lanka's Poisons, Opium and Dangerous Drugs Ordinance (Chapter 218): absent from Groups A, B, C, D and E of the Third Schedule. Quetiapine is not in any Group of the Third Schedule and is not a dangerous drug. It is a registered prescription antipsychotic. The model: the list is inside the Ordinance and the power to change it is delegated, with a parliamentary lock on the delegation. Section 48 provides that 「the drugs, substances, articles or preparations, specified for the time being in Groups A, B, C, D and E in Part I of the Third Schedule, shall be deemed to be dangerous drugs」. Section 2(1) then provides that 「regulation」 means a regulation made under this Ordinance and published in the Gazette, 「and includes the First, Second, Third, Fourth, Fifth and Sixth Schedules」, so the Third Schedule is itself a regulation. The empowering section is section 80. Section 80(2)(b) lets the Minister make regulations 「for adding any item to or deleting any item from, or altering, varying or amending in any other way, any of the lists or Groups of poisons and dangerous drugs set out in the First and Third Schedules」, and section 80(3) then provides that 「No regulation so made shall have effect unless it has been approved by Parliament and notification of such approval has been published in the Gazette」. So the delegation is real but it is locked to an affirmative vote, and in practice the 2022 changes were made by primary legislation rather than by regulation. The Act was last amended by the Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 7 of 2026, certified 6 March 2026. The Third Schedule was last amended by section 6 of the Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022, certified 23 November 2022 and published as a supplement to Part II of the Gazette of 25 November 2022, which substituted Group B of Part I and the whole of Part III. Act No. 7 of 2026 does not touch the Third Schedule.
Consequences if caught
No drugs offence reaches quetiapine in any quantity. Supplying it outside the registered channel is an offence under the National Medicines Regulatory Authority Act, No. 5 of 2015. Capital and life exposure. Neither reaches this substance, and not because the penalty is low but because no dangerous drug offence in this Ordinance engages at all. Section 48 makes a substance a dangerous drug only if it is specified in Groups A to E of Part I of the Third Schedule, and this substance is in none of them. Section 54A(1)(a) names four drugs for the manufacture limb and Part III Column II names five substances for the quantity limbs; this is neither, so no capital or life sentence is available for it on any facts. Saying that much does not dispose of the whole Ordinance, and the corpus this cell replaces never reached the rest of it. Chapter II runs a separate poisons regime over the First Schedule, whose Parts I to V were read in full for this cell, and this substance is named nowhere in them, so sections 5, 17, 18 and 19 create no offence for it either. The instrument that does govern it is named in the status above.
If prescribed or medical
Quetiapine is dispensed on prescription for schizophrenia, bipolar disorder and as an adjunct in depression.
Documentation
Carry a prescribed supply in its dispensed packaging with the prescription. Psychiatric medicines are ordinary medicines for customs purposes here.
Primary sources
  • Poisons, Opium and Dangerous Drugs Ordinance (Chapter 218), as last amended by Act No. 7 of 2026, certified 6 March 2026
  • absence was established by reading Groups A, B, C, D and E of Part I in full, Group B from Act No. 41 of 2022 and Groups A, C, D and E from a private consolidation to 2024, and by reading Parts I to V of the First Schedule and all four Parts of the Second Schedule in that same consolidation
  • the finding is that the substance is absent from Groups A, B, C, D and E of the Third Schedule
  • Third Schedule Groups A to E searched for quetiapine and returning nothing, and National Medicines Regulatory Authority Act, No. 5 of 2015. Principal Ordinance read from the National Dangerous Drugs Control Board's own copy. Read 2026-09-17
  • nddcb.gov.lk
  • nddcb.gov.lk
  • parliament.lk

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Other substances confirmed in Sri Lanka